These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1280531)

  • 1. Failure of anticytokeratin 18 antibody to improve flow cytometric detection of bladder cancer.
    Konchuba AM; Clements MC; Schellhammer PF; Schlossberg SM; Wright GL
    Cancer; 1992 Dec; 70(12):2879-84. PubMed ID: 1280531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric study comparing paired bladder washing and voided urine for bladder cancer detection.
    Konchuba AM; Schellhammer PF; Alexander JP; Wright GL
    Urology; 1989 Feb; 33(2):89-96. PubMed ID: 2916296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine: a suitable sample for deoxyribonucleic acid flow cytometry studies in patients with bladder cancer.
    deVere White RW; Deitch AD; Baker WC; Strand MA
    J Urol; 1988 May; 139(5):926-8. PubMed ID: 3361665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinically applicable method to preserve urine and bladder washing cells for flow cytometric monitoring of bladder cancer patients.
    Deitch AD; Andreotti VA; Strand MA; Howell L; deVere White RW
    J Urol; 1990 Apr; 143(4):700-5. PubMed ID: 2179581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative study of the sensitivity of bladder washing flow cytometry, voided urine cytology and bladder washing cytology in the detection of bladder carcinoma].
    Tachibana M; Jitsukawa S; Tazaki H; Tashiro Y
    Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):1025-30. PubMed ID: 2607716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image cytometric deoxyribonucleic acid analysis of urine specimens as an adjunct to visual cytology in the detection of urothelial cell carcinoma.
    Amberson JB; Laino JP
    J Urol; 1993 Jan; 149(1):42-5. PubMed ID: 8417214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of urinary quantitative immunocytology with monoclonal antibody 486 P3/12 in 241 unselected patients with bladder carcinoma.
    Klän R; Huland E; Baisch H; Huland H
    J Urol; 1991 Mar; 145(3):495-7. PubMed ID: 1997697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of the urinary bladder carcinoma antigen ELISA test and multiparametric DNA/cytokeratin flow cytometry in urine voided samples from patients with bladder carcinoma.
    Sánchez-Carbayo M; Ciudad J; Urrutia M; Navajo JA; Orfao A
    Cancer; 2001 Dec; 92(11):2811-9. PubMed ID: 11753954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixation method useful for cytologic examination and DNA flow cytometry of exfoliated bladder cells.
    Howell LP; Deitch AD; Andreotti VA; Westrick LA; White RD
    Urology; 1993 May; 41(5):472-5. PubMed ID: 7683835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric DNA analysis after immunoselection of bladder tumor cells with monoclonal antibody DU83.21.
    Wright GL; Alexander JP; Konchuba AM; Schellhammer PF; Schlossberg SM
    Cancer; 1990 Sep; 66(6):1242-52. PubMed ID: 1698117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry versus urinary cytology in the diagnosis and follow-up of bladder tumors: critical review of a 5-year experience.
    Billerey C; Lamy B; Bittard H; Rozan S; Carbillet JP
    World J Urol; 1993; 11(3):156-60. PubMed ID: 8401634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DNA ploidy pattern of flow cytometry as indicator of malignancy and prognosis in bladder cancer].
    Hosaka Y
    Nihon Rinsho; 1992 Oct; 50(10):2426-31. PubMed ID: 1447813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acridine-orange flow cytometry of urinary bladder washings for the detection of transitional cell carcinoma of the bladder. The influence of prior local therapy.
    Têtu B; Katz RL; Kalter SP; von Eschenbach AC; Barlogie B
    Cancer; 1987 Oct; 60(8):1815-22. PubMed ID: 3652008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of malignant cells in voided urine from patients with bladder cancer, a novel monoclonal assay.
    Walker KZ; Russell PJ; Kingsley EA; Philips J; Raghavan D
    J Urol; 1989 Dec; 142(6):1578-83. PubMed ID: 2685375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA slit-scan flow cytometry of bladder irrigation specimens and the importance of recognizing urothelial cells.
    Wheeless LL; Reeder JE; O'Connell MJ; Robinson RD; Cosgriff JM; Fradet Y; Frank IN; Cockett AT
    Cytometry; 1991; 12(2):140-6. PubMed ID: 2049971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometry based on heterogeneity index score compared with urine cytology to evaluate their diagnostic efficacy in bladder tumor.
    Jitsukawa S; Tachibana M; Nakazono M; Tazaki H; Addonizio JC
    Urology; 1987 Feb; 29(2):218-22. PubMed ID: 3811103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of flow cytometry in the diagnosis of bladder tumor].
    Ling CH
    Zhonghua Wai Ke Za Zhi; 1989 May; 27(5):286-8, 317. PubMed ID: 2806005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
    Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
    Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.